NCT00361101View on ClinicalTrials.gov

A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

April 30, 2010

Conditions
HIV InfectionsX4 Tropic Virus
Interventions
DRUG

AMD11070

200 mg PO BID (by mouth two times per day) for 10 days.

Trial Locations (2)

32803

Orlando

SW10 9TH

London

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00361101 - A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus | Biotech Hunter | Biotech Hunter